Prioritisation for future surveillance, prevention and control of 98 communicable diseases in Belgium: a 2018 multi-criteria decision analysis study by Sofieke Klamer, Nina Van Goethem, Working group Disease and Criteria selection, Working group Epidemiologists, Daniel Thomas, Els Duysburgh, Toon Braeye, Sophie Quoilin

Connect to this object online.

Conceptual causal framework to assess the effect of SARS-CoV-2 variants on COVID-19 disease severity among hospitalized patients by Nina Van Goethem, Ben Serrien, Mathil Vandromme, Chloé Wyndham-Thomas, Lucy Catteau, Ruben Brondeel, Sofieke Klamer, Marjan Meurisse, Lize Cuypers, Emmanuel André, Koen Blot, Herman Van Oyen

Connect to this object online.

COVID-19 contact tracing in Belgium: main indicators and performance, January - September 2021 by Kristiaan Proesmans, Sharon Hancart, Toon Braeye, Sofieke Klamer, Emmanuel Robesyn, Achille Djiena, Frances De Leeuw, Romain Mahieu, Alex Dreuw, Naima Hammami, Dirk Wildemeersch, Laura Cornelissen, Dieter Van Cauteren

Connect to this object online.

Preclinical In Vivo Evaluation of the Safety of a Multi-shRNA-based Gene Therapy Against HIV-1 by Mireille Centlivre, Nicolas Legrand, Sofieke Klamer, Ying Poi Liu, Karin Jasmijn von Eije, Martino Bohne, Esther Siteur-van Rijnstra, Kees Weijer, Bianca Blom, Carlijn Voermans, Hergen Spits, Ben Berkhout

Connect to this object online.

One year of laboratory-based COVID-19 surveillance system in Belgium: main indicators and performance of the laboratories (March 2020-21) by Marjan Meurisse, Adrien Lajot, Yves Dupont, Marie Lesenfants, Sofieke Klamer, Javiera Rebolledo, Tinne Lernout, Mathias Leroy, Arnaud Capron, Johan Van Bussel, Sophie Quoilin, Emmanuel Andre, Kaat Kehoe, Luc Waumans, Jos Van Acker, Olivier Vandenberg, Sigi Van den Wijngaert, Ann Verdonck, Lize Cuypers, Dieter Van Cauteren

Connect to this object online.